ICMAD Attorney: ‘Bad’ Cosmetics Bill Won’t Get Through Senate, But Next Session Is Less Certain

According to Locke Lord attorney Sharon Blinkoff, general counsel at ICMAD, Senate Health Committee Chair Lamar Alexander is inclined to block cosmetics reform legislation that lacks express industry support. She noted, however, that the Republican senator for Tennessee is retiring at the end of this term.

United States Capitol Building in Washington DC USA

The Independent Cosmetic Manufacturers and Distributors is confident for now that cosmetics reform legislation will not advance in the Senate without broad industry backing, but visibility beyond 2020 is limited, the organization says.

Leading off ICMAD’s FDA Regulatory Workshop May 9 in New York, Corporate Secretary and General Counsel Sharon Blinkoff restated the...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Legislation

US House Passes ‘Do Not Flush’ Legislation For Non-Flushable Personal Care Wipes

 

The US House of Representatives passes legislation requiring manufacturers of non-flushable wet wipes to label products as ‘non-flushable," a move endorsed by the Personal Care Products Council.

California Legislators Advance Bill To Ban Plastic Glitter, Abrasive Microbeads In Personal Care

 
• By 

Lawmakers in California heeded calls from industry to change proposed legislation to avoid a wider ban on microplastics in personal care products.

House Bill Aims to ‘Modernize’ US FDA’s Review Process For Sunscreens

 

Four co-chairs of the House of Representatives’ Skin Cancer Caucus have introduced the Safe Sunscreen Standards Act to direct FDA to establish clearer, ‘more flexible’ standards for evaluating sunscreen ingredients.

House Appropriators’ $3.2Bn For FDA In FY 2026 Includes More Non-User Fee Funds Than Requested

 

A US House bill would give the FDA $33.1m more in budget authority than requested by the Trump Administration for fiscal year 2026. The measure was sent to the full House Appropriations committee on a party-line vote.

More from Policy & Regulation

FDA Urged To Issue Formaldehyde Rule As California Finds Non-Compliance With State Ban

 
• By 

Stakeholders are still waiting for the US FDA to issue its widely anticipated proposed rule to prohibit formaldehyde and formaldehyde releasers from hair smoothing or straightening products.

Cloudy Tariff Conditions Expected To Linger In US

 

White House announces president extends deadline he set in April for other countries to make new tariff deals from July 9 to Aug. 1, when the administration will start sending letters warning other countries that higher tariffs could take effect.

US FDA’s Tough Talk On Talc: Regulating In An Echo Chamber

 

An FDA “expert roundtable” on talc produced a new talking point on a potential drug safety risk, but the basis of that claim is difficult to determine.